drugset / Trial / NCT00668096
A Randomised Study of Levitra to Treat Men With Erections Problems and Previously Untreated With Similar Therapy.
RandomizedParallel-groupDouble-blindTreatment
Summary
The objective of this study was to evaluate the efficacy and tolerability of the phosphodiesterase type 5 inhibitor (PDE5 inhibitor), vardenafil, in a broad population of subjects with erectile dysfunction of different aetiologies and severity, who have not been previously treated with a PDE5 inhibitor; Efficacy and safety was compared with placebo.
Timeline
- Start
- 2004-05
- Primary completion
- 2005-01
- Completion
- 2005-01
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Vardenafil | Small molecule | 5 mg | Oral |
| Subject | Vardenafil | Small molecule | 10 mg | Oral |
| Subject | Vardenafil | Small molecule | 20 mg | Oral |